Verve Therapeutics, Inc. ( VERV) - Price History
Stock symbol VERV is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for VERV (Verve Therapeutics, Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| August 2026 | $11.13 | $11.13 |
| August 2025 | $11.13 | $11.13 |
| July 2025 | $11.13 | $11.13 |
| June 2025 | $11.23 | $11.23 |
| May 2025 | $4.45 | $4.45 |
| April 2025 | $5.67 | $5.67 |
| March 2025 | $4.57 | $4.57 |
| February 2025 | $6.33 | $6.33 |
| January 2025 | $7.61 | $7.61 |
| December 2024 | $5.64 | $5.64 |
| November 2024 | $5.61 | $5.61 |
| October 2024 | $5.73 | $5.73 |
| September 2024 | $4.84 | $4.84 |
| August 2024 | $6.70 | $6.70 |
| July 2024 | $7 | $7 |
| June 2024 | $4.88 | $4.88 |
| May 2024 | $5.19 | $5.19 |
| April 2024 | $6.01 | $6.01 |
| March 2024 | $13.28 | $13.28 |
| February 2024 | $17.05 | $17.05 |
| January 2024 | $10.82 | $10.82 |
| December 2023 | $13.94 | $13.94 |
| November 2023 | $11.28 | $11.28 |
| October 2023 | $12.04 | $12.04 |
| September 2023 | $13.26 | $13.26 |
| August 2023 | $12.87 | $12.87 |
| July 2023 | $20.49 | $20.49 |
| June 2023 | $18.75 | $18.75 |
| May 2023 | $15.48 | $15.48 |
| April 2023 | $15.93 | $15.93 |
| March 2023 | $14.42 | $14.42 |
| February 2023 | $19 | $19 |
| January 2023 | $22.75 | $22.75 |
| December 2022 | $19.35 | $19.35 |
| November 2022 | $23.23 | $23.23 |
| October 2022 | $37.70 | $37.70 |
| September 2022 | $34.35 | $34.35 |
| August 2022 | $38.36 | $38.36 |
| July 2022 | $24.62 | $24.62 |
| June 2022 | $15.28 | $15.28 |
| May 2022 | $15.16 | $15.16 |
| April 2022 | $14.92 | $14.92 |
| March 2022 | $22.82 | $22.82 |
| February 2022 | $32.65 | $32.65 |
| January 2022 | $28.82 | $28.82 |
| December 2021 | $36.87 | $36.87 |
| November 2021 | $34.08 | $34.08 |
| October 2021 | $46.39 | $46.39 |
| September 2021 | $47 | $47 |
| August 2021 | $69.96 | $69.96 |
| July 2021 | $59.43 | $59.43 |
| June 2021 | $60.25 | $60.25 |
VERV
Price: $11.13
52 week price:
Earnings Per Share: -2.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 434163
Market Capitalization: 994.0 million